B Capital led a $106c Series C funding round in Capital Rx.

B Capital, a global investment firm, led a $106c Series C funding round in Capital Rx, a health technology company, with participation from General Catalyst, Transformation Capital and Edison Partners. "Capital Rx has the clearest vision we've seen in the market for how to transform the infrastructure of healthcare to enable better care at a lower cost. AJ and team have made incredible progress in modernizing and unifying the operating platform for prescription drug pricing and delivery, showing industry partners, employers, and American consumers that a new level of care delivery and patient experience is possible for prescription drug access and pricing," Robert Mittendorff, B Capital General Partner.